Original Query: ALL
Previous Study | Return to List | Next Study

Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian Cancer (TRIAS 2009)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01047891
Recruitment Status : Completed
First Posted : January 13, 2010
Last Update Posted : February 18, 2015
Information provided by (Responsible Party):
JSehouli, Charite University, Berlin, Germany

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2015
  Study Completion Date : February 2015